series-c-plus
Stage
1
Investors
About
Dune Medical Devices develops proprietary tissue characterization technology that enables real-time cancer detection during surgery, including the FDA-approved MarginProbe System used to reduce re-operation rates in breast cancer surgery.
Explore Dune Medical Devices's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.